{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=aztreonam&page=2", "query": { "intervention": "aztreonam", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=aztreonam&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T04:20:29.662Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03137173", "title": "Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Bacterial Skin and Skin Structure Infections" ], "interventions": [ { "name": "ceftobiprole medocaril", "type": "DRUG" }, { "name": "vancomycin+aztreonam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Basilea Pharmaceutica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 679, "start_date": "2018-02-19", "completion_date": "2019-04-22", "has_results": true, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 16, "location_summary": "Anaheim, California • Chula Vista, California • Fresno, California + 10 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03137173" }, { "nct_id": "NCT01659866", "title": "Antibiotic Prophylaxis for Transrectal Prostate Biopsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Infection" ], "interventions": [ { "name": "Ciprofloxacin", "type": "DRUG" }, { "name": "trimethoprim-sulfamethoxazole", "type": "DRUG" }, { "name": "cefuroxime", "type": "DRUG" }, { "name": "ceftriaxone", "type": "DRUG" }, { "name": "gentamicin", "type": "DRUG" }, { "name": "amikacin", "type": "DRUG" }, { "name": "aztreonam", "type": "DRUG" }, { "name": "imipenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "90 Years", "sex": "MALE", "summary": "30 Years to 90 Years · Male only" }, "enrollment_count": 563, "start_date": "2012-08", "completion_date": "2016-08", "has_results": true, "last_update_posted_date": "2019-06-25", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01659866" }, { "nct_id": "NCT03329092", "title": "A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Intra-abdominal Infection", "Hosptial Acquired Pneumonia", "Ventilator Associated Pneumonia" ], "interventions": [ { "name": "ATM-AVI", "type": "DRUG" }, { "name": "MTZ", "type": "DRUG" }, { "name": "MER", "type": "DRUG" }, { "name": "COL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 422, "start_date": "2018-04-05", "completion_date": "2023-02-23", "has_results": true, "last_update_posted_date": "2024-12-10", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 5, "location_summary": "Tucson, Arizona • Torrance, California • Springfield, Illinois", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Torrance", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Springfield", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03329092" }, { "nct_id": "NCT01375049", "title": "Aztreonam Lysine for Pseudomonas Infection Eradication Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Aztreonam for Inhalation Solution (AZLI)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Months to 17 Years" }, "enrollment_count": 105, "start_date": "2011-08", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2014-07-17", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Jacksonville, Florida • Orlando, Florida + 20 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01375049" }, { "nct_id": "NCT00112359", "title": "International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "AZLI 75 mg three times a day (TID)", "type": "DRUG" }, { "name": "Placebo three times a day (TID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 166, "start_date": "2005-05", "completion_date": "2007-04", "has_results": true, "last_update_posted_date": "2011-04-21", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00112359" }, { "nct_id": "NCT01400867", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections, Pediatrics" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam", "type": "DRUG" }, { "name": "Cephalexin or Clindamycin or Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Months to 17 Years" }, "enrollment_count": 163, "start_date": "2011-12", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 28, "location_summary": "Phoenix, Arizona • Orange, California • San Diego, California + 23 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400867" }, { "nct_id": "NCT00712166", "title": "Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis", "Lung Infection", "Pseudomonas Aeruginosa" ], "interventions": [ { "name": "AZLI 75 mg three times daily (TID)", "type": "DRUG" }, { "name": "Placebo three times daily (TID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 160, "start_date": "2008-05", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2010-12-20", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 34, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 26 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00712166" }, { "nct_id": "NCT01736839", "title": "Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cystic Fibrosis in Adults, Chronic Colonization With Pseudomonas Aeruginosa" ], "interventions": [], "intervention_types": [], "sponsor": "National Jewish Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 23, "start_date": "2012-11", "completion_date": "2017-07-27", "has_results": false, "last_update_posted_date": "2020-03-24", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01736839" }, { "nct_id": "NCT01469364", "title": "Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Complication of Transplanted Lung" ], "interventions": [ { "name": "Aztreonam Lysine for Inhalation (AZLI)", "type": "DRUG" }, { "name": "Status Post Lung Transplant", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2013-03", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-01-29", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 2, "location_summary": "Los Angeles, California • Durham, North Carolina", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01469364" }, { "nct_id": "NCT03138733", "title": "Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Staphylococcus Aureus Bacteremia" ], "interventions": [ { "name": "Ceftobiprole medocaril", "type": "DRUG" }, { "name": "Daptomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Basilea Pharmaceutica", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 390, "start_date": "2018-08-26", "completion_date": "2022-03-11", "has_results": true, "last_update_posted_date": "2023-11-08", "last_synced_at": "2026-09-25T04:20:29.662Z", "location_count": 5, "location_summary": "Chula Vista, California • West Palm Beach, Florida • Butte, Montana + 2 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Butte", "state": "Montana" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03138733" } ] }